Gibt es Geschlechterunterschiede bei Infektionen?

Kernaussagen

Nicht nur die anatomischen Unterschiede von Frauen und Männern tragen zu den unterschiedlichen Manifestationen und Häufigkeiten von Infektionskrankheiten bei beiden Geschlechtern bei, sondern auch weitere wichtige Faktoren wie Hormone, Immunsystem und ihre Gender-Rolle in der Gesellschaft. Diese Unterschiede sind im Hinblick auf Präventivmaßnahmen zunehmend zu berücksichtigen.

• Literatur

• 1 Schroder J, Kahlke V, Staubach KH et al. Gender differences in human sepsis. Arch Surg 1998; 133: 1200-1205
• 2 Offner PJ, Moore EE, Biffl WL. Male gender is a risk factor for major infections after surgery. Arch Surg 1999; 134: 935-938 ; discussion 8-40
• 3 Wichmann MW, Inthorn D, Andress HJ et al. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 2000; 26: 167-172
• 4 Eachempati SR, Hydo L, Barie PS. Gender-based differences in outcome in patients with sepsis. Arch Surg 1999; 134: 1342-1347
• 5 Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol 2010; 10: 594-604
• 6 Mnyani CN, McIntyre JA. Tuberculosis in pregnancy. Br J Obstet Gynecol 2011; 118: 226-231
• 7 Gonzalez DA, Diaz BB, Rodriguez Perez Mdel C et al. Sex hormones and autoimmunity. Immunol Lett 2010; 133: 6-13
• 8 Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. J Autoimmun 2007; 28: 1-6
• 9 Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103-e120
• 10 Wagenlehner FM, Schmiemann G, Hoyme U et al. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients]. Urologe A 2011; 50: 153-169
• 11 Pietropaoli AP, Glance LG, Oakes D et al. Gender differences in mortality in patients with severe sepsis or septic shock. Gend Med 2010; 7: 422-437
• 12 Nachtigall I, Tafelski S, Rothbart A et al. Gender-related outcome difference is related to course of sepsis on mixed ICUs: a prospective, observational clinical study. Crit Care 2011; 15: R151
• 13 WHO ed Global prevalence and incidence of selected curable sexually transmitted infections, overview and estimates. WHO; 2001
• 14 Pedlow CT, Carey MP. Developmentally appropriate sexual risk reduction interventions for adolescents: rationale, review of interventions, and recommendations for research and practice. Ann Behav Med 2004; 27: 172-184
• 15 European Commission. European Survey on Sexually Transmitted Infections: Sexually transmitted infections – Surveillance in Europe. 2008
• 16 European Centers of Disease Control. Technical Report Mapping of HIV/STI behavioural surveillance. 2009
• 17 Laspina F, Samudio M, Cibils D et al. Epidemiological characteristics of microbiological results on patients with infectious corneal ulcers: a 13-year survey in Paraguay. Graefes Arch Clin Exp Ophthalmol 2004; 242: 204-209
• 18 Cedrone C, Ricci F, Regine F et al. Nationwide incidence of endophthalmitis among the general population and the subjects at risk of endophthalmitis in Italy. Ophthalmic Epidemiol 2008; 15: 366-371
• 19 Essex RW, Yi Q, Charles PG et al. Post-traumatic endophthalmitis. Ophthalmology 2004; 111: 2015-2022
• 20 Erikson K. Smittkoppornas konsekvenser. En studie över smittade födda 1780–1785 i Skelefftea landsförsamling. Unpublished paper. Department of History, Umea University; 1994 – Dank an Frau Prof. Dr. Birgitta Evengard, Dept. Infectious Diseases, Umea University
• 21 Robert-Koch-Institut. Infektionsbiologisches Jahrbuch für 2010. Berlin: 2011
• 22 Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 2010; 10: 338-349
• 23 Gaucher D, Therrien R, Kettaf N et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008; 205: 3119-3131
• 24 Engler RJ, Nelson MR, Klote MM et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004–2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008; 168: 2405-2414
• 25 Mossong J, O'Callaghan CJ, Ratnam S. Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population. Vaccine 2000; 19: 523-529
• 26 Davidkin I, Valle M, Julkunen I. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up. Vaccine 1995; 13: 1617-1622
• 27 France EK, Glanz J, Xu S et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 2008; 121: e687-e692
• 28 Hilber AM, Bosch-Capblanch X, Schindler C et al. Gender and immunisation. Summary report for SAGE, November 2010. Zürich: Swiss Centre for International Health STaPHI; 2010
• 29 Soneji S, Metlay J. Mortality reductions for older adults differ by race/ethnicity and gender since the introduction of adult and pediatric pneumococcal vaccines. Public Health Rep 2011; 126: 259-269
• 30 Marek E, Dergez T, Rebek-Nagy G et al. Adolescents’ awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Vaccine 2011; 29: 8591-8598
• 31 Allen JD, de Jesus M, Mars D et al. Decision-making about the HPV vaccine among ethnically diverse parents: implications for health communications. J Oncol 2012; 401979
• 32 Mamelund SE, Riise Bergsaker MA. Vaccine history, gender and influenza vaccination in a household context. Vaccine 2011; 29: 9441-9450